Literature DB >> 22437867

Tumour immunology: suppressing tumorigenic inflammation.

Gemma K Alderton.   

Abstract

Entities:  

Year:  2012        PMID： 22437867     DOI： 10.1038/nrc3252

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras.

Authors:  Yael Gus-Brautbar; Derek Johnson; Li Zhang; Honghong Sun; Peng Wang; Shirley Zhang; Lining Zhang; Youhai H Chen
Journal:  Mol Cell       Date:  2012-02-08       Impact factor: 17.970
  1 in total
  4 in total

1.  Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial-mesenchymal transition.

Authors:  H Yin; X Huang; M Tao; Q Hu; J Qiu; W Chen; J Wu; Y Xie
Journal:  Cancer Gene Ther       Date:  2017-02-10       Impact factor: 5.987

2.  A pan-cancer modular regulatory network analysis to identify common and cancer-specific network components.

Authors:  Sara A Knaack; Alireza Fotuhi Siahpirani; Sushmita Roy
Journal:  Cancer Inform       Date:  2014-10-28

3.  Cancer Immunotherapy and Personalized Medicine: Emerging Technologies and Biomarker-Based Approaches.

Authors:  Laura Maciejko; Munisha Smalley; Aaron Goldman
Journal:  J Mol Biomark Diagn       Date:  2017-06-28

Review 4.  Marketed drugs used for the management of hypercholesterolemia as anticancer armament.

Authors:  Panagiota Papanagnou; Theodora Stivarou; Ioannis Papageorgiou; Georgios E Papadopoulos; Anastasios Pappas
Journal:  Onco Targets Ther       Date:  2017-09-08       Impact factor: 4.147
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.